OVASUITE

What this means for you

Not registered yet, but its 08 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

97584013

Mark type

Stylized text

Filed

08 Sept 2022

Attorney of record

Melissa Hunter-Ensor

Goods and services

• Class 042 — Scientific and technological services: Providing reagent sample testing and diagnostic services for others for scientific research purposes; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; providing medical and scientific research information; providing medical and scientific research information in the field of cancer detection and clinical trials; providing medical and scientific research information in the field of ovarian cancer detection and clinical trials; providing medical and scientific research information in the field of breast cancer detection and clinical trials; providing medical and scientific research services in the field of biomarker testing and cancer screening; medical and scientific research services in the field of cancer treatment and diagnosis; medical and scientific research services in the field of ovarian cancer treatment and diagnosis; medical and scientific research services in the field of breast treatment and diagnosis; medical and scientific research services in the field of cancer treatment and diagnosis; medical and scientific research services in the fields of women's health, genetics, gynecology and cancer; scientific research consulting in the field of genetics; product development in the fields of women's health, genetics, gynecology, diagnostics and cancer; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; consulting services in the fields of laboratory testing and diagnostics; providing a web hosting platform for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; platform as a service (PAAS) featuring computer software platforms for diagnostic testing in the field of women's health; software as a service (SAAS) services featuring software for diagnostic testing; software as a service (SAAS) services featuring software for cancer diagnostic testing; software as a service (SAAS) services featuring software for genetic testing; software as a service (SAAS) services featuring software using artificial intelligence for medical diagnostic testing; providing on-line non-downloadable software using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; providing temporary use of on-line non-downloadable software and applications using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; providing a website featuring non-downloadable software using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing

Owner

• Aspira Women's Health Inc., Austin, TX, US

Prosecution history

• 25 Jan 2026 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
• 24 Jul 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
• 23 Jul 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
• 22 Jan 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
• 02 Jan 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
• 19 Jan 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 19 Jan 2024 — LETTER OF SUSPENSION E-MAILED
• 19 Jan 2024 — SUSPENSION LETTER WRITTEN
• 22 Dec 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 21 Dec 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 21 Dec 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 19 Sept 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
• 19 Sept 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
• 24 Jun 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 24 Jun 2023 — NON-FINAL ACTION E-MAILED